Education
About Us
Working with TipRanks
Follow Us
Novo Nordisk A/S (UK) (GB:0QIU)
:0QIU
0QIU Analyst Ratings
Moderate Buy
7 Buy
4 Hold
2 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
0QIU Stock 12 Month Forecast
Average Price Target
kr604.17
▲(34.88%Upside)
| Highest Price Targetkr750.00 | Average Price Targetkr604.17 | Lowest Price Targetkr330.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Deutsche Bank
kr750
Buy
67.43%
Upside
Reiterated
07/09/25
Bank of America Securities
kr850→kr550
Buy
22.78%
Upside
Reiterated
07/01/25
J.P. Morgan
kr650
Buy
45.11%
Upside
Reiterated
06/30/25
Goldman Sachs
kr775→kr745
Buy
66.32%
Upside
Reiterated
06/30/25
Morgan Stanley
kr550
Hold
22.78%
Upside
Reiterated
06/23/25
Kepler Capital
kr630
Buy
40.64%
Upside
Reiterated
06/23/25
Jefferies
kr415
Sell
-7.35%
Downside
Reiterated
06/23/25
Bernstein
kr620
Hold
38.41%
Upside
Reiterated
06/12/25
Berenberg Bank
kr610
Hold
36.18%
Upside
Reiterated
05/16/25
DZ BANK AG
―
Hold
―
Reiterated
05/08/25
DBS
kr330
Sell
-26.33%
Downside
Downgraded
04/24/25
Stifel Nicolaus
kr780→kr700
Hold
56.27%
Upside
Downgraded
03/03/25
Guggenheim
kr795→kr798
Buy
78.15%
Upside
Reiterated
01/17/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Deutsche Bank
kr750
Buy
67.43%
Upside
Reiterated
07/09/25
Bank of America Securities
kr850→kr550
Buy
22.78%
Upside
Reiterated
07/01/25
J.P. Morgan
kr650
Buy
45.11%
Upside
Reiterated
06/30/25
Goldman Sachs
kr775→kr745
Buy
66.32%
Upside
Reiterated
06/30/25
Morgan Stanley
kr550
Hold
22.78%
Upside
Reiterated
06/23/25
Kepler Capital
kr630
Buy
40.64%
Upside
Reiterated
06/23/25
Jefferies
kr415
Sell
-7.35%
Downside
Reiterated
06/23/25
Bernstein
kr620
Hold
38.41%
Upside
Reiterated
06/12/25
Berenberg Bank
kr610
Hold
36.18%
Upside
Reiterated
05/16/25
DZ BANK AG
―
Hold
―
Reiterated
05/08/25
DBS
kr330
Sell
-26.33%
Downside
Downgraded
04/24/25
Stifel Nicolaus
kr780→kr700
Hold
56.27%
Upside
Downgraded
03/03/25
Guggenheim
kr795→kr798
Buy
78.15%
Upside
Reiterated
01/17/25
Best Analysts Covering Novo Nordisk
1 Month
xxx
Success Rate
35/58 ratings generated profit
Average Return
+1.18%
reiterated a xxx
rating 14 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 60.34% of your transactions generating a profit, with an average return of +1.18% per trade.
3 Months
xxx
Success Rate
39/59 ratings generated profit
Average Return
+3.81%
reiterated a xxx
rating 5 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.10% of your transactions generating a profit, with an average return of +3.81% per trade.
1 Year
Success Rate
25/34 ratings generated profit
Average Return
+22.45%
reiterated a buy rating 21 days ago
Copying Emily Field's trades and holding each position for 1 Year would result in 73.53% of your transactions generating a profit, with an average return of +22.45% per trade.
2 Years
xxx
Success Rate
34/58 ratings generated profit
Average Return
+22.14%
reiterated a xxx
rating 14 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 58.62% of your transactions generating a profit, with an average return of +22.14% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
0QIU Analyst Recommendation Trends
Rating
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Strong Buy
20
26
32
33
22
Buy
25
15
7
8
9
Hold
17
15
13
10
7
Sell
4
5
5
5
2
Strong Sell
0
0
0
0
0
total
66
61
57
56
40
Each month's total comprises the sum of three months' worth of ratings.
0QIU Financial Forecast
0QIU Stock Forecast FAQ
What is GB:0QIU’s average 12-month price target, according to analysts?
Based on analyst ratings, Novo Nordisk A/S (UK)’s 12-month average price target is 604.17.
What is GB:0QIU’s upside potential, based on the analysts’ average price target?
Novo Nordisk A/S (UK) has 34.88% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Novo Nordisk A/S (UK) a Buy, Sell or Hold?
Novo Nordisk A/S (UK) has a consensus rating of Moderate Buy, which is based on 7 buy ratings, 4 hold ratings and 2 sell ratings.
What is Novo Nordisk A/S (UK)’s share price target?
The average share price target for Novo Nordisk A/S (UK) is 604.17. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is kr750.00 ,and the lowest forecast is kr330.00. The average share price target represents 34.88% Increase from the current price of kr447.94.
The highest analyst share price target is kr750.00 ,and the lowest forecast is kr330.00. The average share price target represents 34.88% Increase from the current price of kr447.94.
What do analysts say about Novo Nordisk A/S (UK)?
Novo Nordisk A/S (UK)’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.
How can I buy shares of Novo Nordisk A/S (UK)?
To buy shares of GB:0QIU, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.